28 items
2026-09-11
HUMAN MADE Inc., Board Meeting, Sep 11, 2026. Agenda: To consider the Execution of Share Purchase Agreement for UNDER COVER CO., LTD.
2026-09-11
HUMAN MADE Inc. revised consolidated earnings guidance for the full year ending January 31, 2027. For the period, the company expects net sales to be JPY 19,200 million, operating income to be JPY 5,300 million, net income attributable to owners of parent to be JPY 3,700 million or JPY 40.37 per share against pervious guidance net sales to be JPY 18,500 million, operating income to be JPY 4,800 million, net income attributable to owners of parent to be JPY 3,300 million or JPY 36.00 per share.
2026-07-23
HUMAN MADE Inc. announced that the Board of Directors at its meeting held on July 23, 2026, resolved to introduce an Executive Officer system and change the title of the Representative Director. Introduction of the Executive Officer System: The Company will introduce an Executive Officer system to respond to business expansion and rapid changes in the management environment. This transition is intended to accelerate decision-making, improve the efficiency of business execution, establish a more agile management structure, expand opportunities for the appointment of management personnel, and foster management talent over the medium to long term. Overview of the Executive Officer System: Executive Officers shall be engaged under mandate contract with the Company. The appointment and dismissal of Executive Officers shall be resolved by the Board of Directors. The term of office for Executive Officers shall be one year, and they are not precluded from being reappointed. Executive Officers shall execute business operations based on the business policies determined by the Board of Directors. Scheduled Date of Introduction: August 1, 2026. Change in Title of Representative Director (effective as of August 1, 2026): Effective August 1, 2026, Rei Matsunuma's title will change from Representative Director, CEO and COO to Representative Director and CEO. At the same time, Yuki Yamanaka, currently General Manager of the Product Department, will be appointed as Head of Product; Tatsuya Shiraishi, currently General Manager of the Global Business Department, will be appointed as Head of Revenue; and Itaru Yamamoto, currently Team Leader of FP&A and IR in the Accounting & Finance Department and Team Leader of Corporate Strategy in the Corporate Planning Department, will be appointed Head of Finance. Yuki Yamanaka, born on January 16, 1989, began his career at UNIQLO Co. Ltd. in March 2011 before joining the Company in March 2021. He was appointed Unit Manager of the Product Development and Product Planning Unit within the Business Management Department in May 2022 and later became General Manager of the Product Department in May 2024. Tatsuya Shiraishi, born on July 22, 1976, started his career at Pioneer Corporation in April 1999 and joined UNIQLO Co. Ltd. in January 2011. He subsequently joined Rakuten Group Inc. in January 2019 and giftee Inc. in January 2021 before joining the Company in September 2021. In May 2022, he was appointed Unit Manager of the E-commerce & Logistics Unit within the Business Management Department, and in May 2024, he became General Manager of the Global Business Department. Itaru Yamamoto, born on August 4, 1980, began his professional career with AZSA & Co. (now KPMG AZSA LLC) in October 2005 and later joined PricewaterhouseCoopers Co. Ltd. (now PwC Advisory LLC) in November 2012. He joined the Company in April 2025 .
2026-07-23
HUMAN MADE Inc., Board Meeting, Jul 23, 2026. Agenda: To introduce an Executive Officer system and change the title of the Representative Director accordingly; and to consider other business matters.
2026-07-17
HUMAN MADE Inc. announced that they will report Q2, 2027 results on Sep 11, 2026
2026-06-25
HUMAN MADE Inc. reported earnings results for the first quarter ended April 30, 2026. For the first quarter, the company reported sales was JPY 4,299.9 million. Net income was JPY 870.74 million. Basic earnings per share from continuing operations was JPY 9.5. Diluted earnings per share from continuing operations was JPY 9.28.
2026-06-21
HUMAN MADE Inc.(TSE:456A) added to S&P Global BMI Index
2026-06-15
HUMAN MADE Inc. provided non-consolidated earnings guidance for the fiscal year fiscal year ending January 31, 2027. For the full year, the company expects sales of JPY 18,500 million; Operating income of JPY 4,800 million; Net income of JPY 3,300 million; Earnings per share of JPY 36.01. The Company implemented the stock split on May 1, 2026. Earnings per share based on the financial results forecasts for the fiscal year ended January 31, 2027, are calculated based on the impact of the stock split.
2026-06-15
HUMAN MADE Inc. (TSE:456A) signed a letter of intent to acquire Undercover Co., Ltd from Jun Takahashi and Hiroshi Takahashi on June 15, 2026. The expected closing date of this transaction is February 2027.
2026-06-15
HUMAN MADE Inc., Board Meeting, Jun 15, 2026. Agenda: To consider to enter into a Letter of Intent regarding the acquisition of all shares of UNDERCOVER CO., LTD.
2026-05-22
HUMAN MADE Inc. announced that they will report Q1, 2027 results on Jun 15, 2026
2026-05-22
HUMAN MADE Inc., Board Meeting, May 22, 2026. Agenda: To consider and approve the Issuance of New Shares as Restricted Stock Remuneration.
2026-04-09
HUMAN MADE Inc. announced that they will report fiscal year 2026 results on Mar 16, 2026
2026-03-30
HUMAN MADE Inc. reported earnings results for the full year ended January 31, 2026. For the full year, the company reported sales was JPY 14,273.23 million. Net income was JPY 2,941.12 million. Basic earnings per share from continuing operations was JPY 132.78. Diluted earnings per share from continuing operations was JPY 129.59.
2026-03-26
HUMAN MADE Inc., Board Meeting, Mar 26, 2026. Agenda: To consider resolution to revise its remuneration system for Directors and introduce a restricted stock remuneration plan.
2026-03-20
HUMAN MADE Inc. at its board of directors meeting held on March 16, 2026, approved changes to its Articles of Incorporation, effective May 1, 2026, corresponding to a share split. The total number of shares authorized to be issued by the Company was changed from 87,920,000 to 351,680,000.
2026-03-20
HUMAN MADE Inc. hereby announces that at a meeting of the Board of Directors held on October 14, 2025, a resolution was passed to establish a new subsidiary in the United States of America. The procedures of the establishment have been completed as described below. The Company has been pursuing global business expansion as a key component of its growth strategy and considers the United State of America as one of the most important countries with large market size. Therefore, the Company determined to establish a subsidiary in China to proceed preparation for business expansion. Company Name HUMAN MADE USA Inc. Location Delaware, United States of America Business activities Retail business in the United State Capital USD 4,000,000 (approx. JPY 620,000,000) Rate: 1 USD/155JPY Establishment March 16, 2026 Shareholder Composition 100% owned by the Company The impact of the matter on consolidated financial results for the fiscal year ending January 2027 has been incorporated into earnings forecasts disclosed on March 16. The company will promptly announce any matters that require disclosure as they arise. Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
2026-03-20
HUMAN MADE Inc. provided consolidated earnings guidance for the fiscal year ending March 31, 2026. For the full year, the company expects operating revenue of JPY 18,500 million; Operating profit of JPY 4,800 million; Net income of JPY 3,300 million; Earnings per share of JPY 36.01.
2026-03-17
HUMAN MADE Inc., 4 : 1, Stock Split or Significant Stock Dividend, Apr-28-2026
2026-03-16
HUMAN MADE Inc., Annual General Meeting, Apr 28, 2026.
2026-03-16
HUMAN MADE Inc., Board Meeting, Mar 16, 2026. Agenda: To consider and approve to implement a stock split at a ratio of 4 shares per share effective May 1, 2026.
2026-03-12
HUMAN MADE Inc. (the “Company”) hereby announces that the procedures of the establishment of the subsidiary in China have been completed as described below. The Company has been pursuing global business expansion as a key component of its growth strategy and considers China as one of the most important countries with large market size. Therefore, the Company determined to establish a subsidiary in China to proceed preparation for business expansion. (1) Company Name: HUMAN MADE CHINA Inc. (2) Location Shanghai, People's Republic of China (3) Representative Rei Matsunuma, Representative Director, CEO, and COO of the Company (4) Business activities Retail business in China (5) Capital RMB 25,000,000 (approx. JPY 570,000,000). (6) Establishment March 2, 2026 (7) Shareholder Composition 100% owned by the Company.
2026-03-02
HUMAN MADE Inc. expected to report Q1 2027 results on June 11, 2026. This event was calculated by S&P Global (Created on March 2, 2026).
2026-02-25
HUMAN MADE Inc., Board Meeting, Feb 25, 2026. Agenda: To consider to establish the Nomination and Remuneration Committee as a voluntary advisory committee to the Board of Directors.
2025-12-02
HUMAN MADE Inc. announced that they will report Q3, 2026 results on Dec 12, 2025
2025-11-27
Certain Common Stock of HUMAN MADE Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2026. These Common Stock will be under lockup for 179 days starting from 27-NOV-2025 to 25-MAY-2026. Details: In connection with this offering and the underwriting purchase and underwriting sale, Tomoaki Nagao, the seller and share lender, Pharrell Williams and NIGOLD Co., Ltd., also sellers, and Brian Donnelly and Satoshi Tanaka, the stock acquisition right holders of the Company, have agreed with the joint lead managers that they will not sell, etc., the Company's common shares (excluding, however, the underwriting purchase and underwriting sale by the underwriters, the lending of the Company's common shares for the offering by way of over-allotment, and the acquisition by Nomura Securities Co., Ltd. of the Company's common shares subject to the green shoe option) during the period from the execution date of the principal underwriting agreement until May 25, 2026, which is the 180th day after the listing (trading commencement) date (including that day), without the prior written consent of the joint lead managers. Furthermore, the sellers, Matsunuma Rei, Yanagisawa Junichi and Hatoyama Reiji, have agreed with the joint lead managers that they will not sell, etc., the company's common stock (excluding sales, etc. through purchase and underwriting by the underwriters) during the period from the date of the original underwriting agreement to November 21, 2026, which is 360 days after the listing (commencement of trading) date (including that date) without the prior written consent of the joint lead managers. In addition, the Company has agreed with the joint lead managers that during the period from the date of the execution of the principal underwriting agreement until May 25, 2026, which is the 180th day after the listing (trading commencement) date (including that day), the Company will not issue any of its common shares, any securities that can be converted into or exchanged for its common shares, or any securities that confer the right to acquire or receive its common shares (excluding this offering, stock splits, and the issuance of stock acquisition rights as stock options, etc.) without the prior written consent of the joint lead managers.
2025-11-27
HUMAN MADE Inc. has completed an IPO in the amount of ¥17.751482 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 931,400 Price\Range: ¥3130 Discount Per Security: ¥219.1 Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,740,000 Price\Range: ¥3130 Discount Per Security: ¥219.1
2025-10-23
Human Made Inc. has filed an IPO. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,671,400
2026Q2 | 2026Q1 | 2025Q4 | 2024Q4 | 2023Q4 | |
|---|---|---|---|---|---|
Total Revenues | 17,045 | 15,580 | 14,273 | 11,258 | 8,390 |
Pretax Income Excl.Unusual Items | 4,999 | 4,650 | 4,333 | 3,177 | 2,256 |
Total Assets | 16,948 | 15,353 | 14,514 | 8,243 | 5,711 |
Total Liabilities | 3,385 | 2,682 | 2,715 | 2,095 | 1,692 |
Cash & Cash Equivalents | 10,409 | 9,335 | 9,973 | 5,709 | 3,880 |
Total Common Equity | 13,563 | 12,671 | 11,799 | 6,148 | 4,019 |
Book Value Per Share (BVPS) | 147.96 | 138.26 | 128.75 | 69.93 | 50.22 |
Net Change in Cash | 4,464 | 1,629 | |||
Capital Expenditure | -891 | -177 |
As of September 14, 2026, HUMAN MADE Inc. published financial results for the second quarter of 2026, with revenues of 4.46B yen and net income of 848.26M yen, indicating a significant 49% surge in revenues, in addition to a substantial 39.1% rise in EPS compared to the corresponding quarter of the previous year.
and it trades at 12.8x times current year's earnings, which is higher than the sector average (P/E 11x).